Safe Financial Buffer in Clinical Trials: Learn the Recommendations from CRO Experts

Safe Financial Buffer in Clinical Trials: Learn the Recommendations from CRO Experts

Planning the budget for a clinical or non-interventional trial is a process that requires precision, experience, and a realistic risk assessment. While sponsors often focus on direct costs—visits, procedures, site compensation, and project management—practice shows that unforeseen expenses are the most common cause of delays, schedule changes, or the need to renegotiate the budget. This is why a financial buffer, already included in the planning stage, is one of the key elements of a well-managed study.

CRO experts recommend that, in the early stages of the project, a buffer of 10–30% of the total budget should be planned, depending on the complexity of the protocol, the number of sites, and the study population. Lower values are effective in short-term and well-standardized studies, while in multi-center projects, with new technologies or high operational risk, a buffer closer to the upper limit is safer.

The budget reserve covers areas such as: additional patient visits, equipment orders, higher-than-expected shipping costs, increased number of monitoring visits, the need to expand CRO activities, adjusting eCRF/eTMF, training new personnel at the site, recruitment extension, or unplanned medical actions related to participant safety. In practice, these categories account for most of the financial deviations in clinical projects.

Including a buffer at the outset does not mean increasing costs—it means controlling them. The reserve allows the study to be conducted without compromising quality, while also protecting sponsors from the need for sudden payments at crucial points in the project. This is especially important in light of increasing regulatory demands and pressure for timely delivery of results.

If you want to ensure that your study's budget is realistically planned and includes an appropriate financial buffer, schedule a free consultation with our CRO experts. Our experienced team will help assess risks, verify assumptions, and prepare a budget resilient to unexpected challenges.

Other questions: Budget and research financing

See also

How long do CRO contract negotiations take, and why is it worth planning them carefully? How long do CRO contract negotiations take, and why is it worth planning them carefully?
Negotiating a contract with a CRO is one of the key stages in preparing a clinical trial, yet it is often underestimated in the project timeline. Sponsors us...
What are the potential funding sources for non-commercial research beyond public grants? What are the potential funding sources for non-commercial research beyond public grants?
Non-commercial research plays an increasingly important role in advancing medicine, especially in areas that do not always offer direct business justificatio...
Insurance Policy in a Clinical Trial as an Element of Safety and Regulatory Compliance Insurance Policy in a Clinical Trial as an Element of Safety and Regulatory Compliance
An insurance policy in a clinical trial is not merely a formal regulatory requirement, but one of the key components of an effective risk management system. ...
Copyright© 2023 Biostat